Ajanta Pharma earmarks Rs 250 crore capex for current fiscal

"During the current year (FY22), we are estimating the capex to be in the vicinity of Rs 250 crore. It will largely go towards maintenance and some new expansions for the corporate office and some key expansions in the facility," Ajanta Pharma Managing Director Yogesh Agrawal said in an analyst call.


via Economictimes

No comments